pembrolizumab

pembrolizumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

Pronunciation:
pem-broe-li-zoo-mab


Trade Name(s)

  • Keytruda

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies
programmed death-1 inhibitors

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

Pronunciation:
pem-broe-li-zoo-mab


Trade Name(s)

  • Keytruda

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies
programmed death-1 inhibitors

There's more to see -- the rest of this entry is available only to subscribers.